Clinical trial
Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety and Tolerability of a Fixed Dose of Remegal as Adjunctive Therapy in Patients With Partial Seizures
NCT01749046 is registered in ClinicalTrials.gov with Valexfarm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety and Tolerability of a Fixed Dose of Remegal as Adjunctive Therapy in Patients With Partial Seizures
- Lead sponsor
- Valexfarm
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- December 31, 2013
- Enrollment
- 224 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
complex partial seizures, epilepsy, partial seizures with secondary generalization, simple partial seizures